ARK Genomic Revolution ETF
ARKG
ARKG
237 hedge funds and large institutions have $699M invested in ARK Genomic Revolution ETF in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 102 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
237
Holders Change
-24
Holders Change %
-9.2%
% of All Funds
3.43%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
22
Increased
37
Reduced
102
Closed
42
Calls
$87.7M
Puts
$73.1M
Net Calls
+$14.6M
Net Calls Change
+$83.2M
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
$74.3M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
$84M |
| 3 |
Goldman Sachs
New York
|
$46.4M |
| 4 |
Citigroup
New York
|
$43M |
| 5 |
JPMorgan Chase & Co
New York
|
$75.7M |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
$33.8M |
| 2 |
MMEA
Main Management ETF Advisors
San Francisco,
California
|
$62.2M |
| 3 |
GS
GTS Securities
New York
|
$2.14M |
| 4 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
$1.03M |
| 5 |
Morgan Stanley
New York
|
$36.2M |
